GAITHERSBURG, Md., Nov. 18, 2022 /PRNewswire/ -- Novavax, Inc. (NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, ...
Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...
WAKE COUNTY, N.C. (WTVD) -- A fourth vaccine could soon be added to the arsenal of weapons against the novel Coronavirus. Triangle residents played a role in the successful trials of the Novavax ...
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at ...
The Biden administration announced Monday that it would purchase 3.2 million doses of the Novavax COVID-19 vaccine. It will be offered at no cost to states and federal partners. “We remain committed ...
Following its emergency authorization last month, just 7,300 doses of Novavax's COVID-19 vaccine have been administered to Americans across the country, newly updated data from the Centers for Disease ...
NEW YORK -- The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. American adults who haven't yet gotten vaccinated against COVID-19 should consider a new option ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
Assignment of the lease for the facility and sale of assets are expected to close in January and result in $40 million in payments to Novavax, while the sale of property adjacent to the headquarters ...
How the United States' potential fourth vaccine stacks up against existing ones. Maryland-based biotech company Novavax said Monday that its COVID-19 vaccine was shown to be highly effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback